Acute Porphyria Drug Database

Monograph

D11AX16 - Eflornithine
Propably not porphyrinogenic
PNP

Rationale
Eflornithine is administered topically and hepatic exposure is insignificant. Eflornithine is excreted in urine as unchanged drug and no metabolism is recognized.
Chemical description
Ornithine decarboxylase inhibitor, alpha-difluoromethylornitine
Therapeutic characteristics
Eflornithine is used in the treatment of facial hirsutism in women. It is applied topically.
Hepatic exposure
Cmax of efornithine is approximately 10 ng/mL (Malhotra 2001). This is equivalent to 0.05 µM and hepatic exposure is insignificant.
Metabolism and pharmacokinetics
Eflornithine is not known to be metabolized and is eliminated in the urine as unchanged drug (SPC). Less than 1 % of the drug is absorbed following topical application (Martindale).

References

# Citation details PMID
*Scientific articles
1. Percutaneous absorption and pharmacokinetics of eflornithine HCl 13.9% cream in women with unwanted facial hair.
Malhotra B, Noveck Rm, et al. J Clin Pharmacol. 2001 Sep;41(9):972-8.
11549102
*Drug reference publications
2. Martindale in Micromedex® 2.0 (electronic version). Eflornithine. (12.05.2015).
*Summary of Product Characteristics
3. The electronic Medicines Compendium (emc). Summary of Product Characteristics (SPC). (Vaniqa).

Similar drugs
Explore alternative drugs in similar therapeutic classes D11A / D11AX or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Vaniqa · Vaniqa 11,5% Crème, crème
United Kingdom
Vaniqa · Vaniqa 11.5% cream
Denmark
Vaniqa
Norway
Vaniqa
Poland
Vaniqa
Luxembourg
VANIQA
Iceland
Vaniqa
Finland
Vaniqa
Latvia
Vaniqa
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙